Urinary incontinence neuromod newcomer Amber Therapeutics nets $100M
The University of Oxford spinout's series A round follows up on positive preliminary data from a first-in-human trial earlier this year.
Source: fiercebiotech.com
Stay updated with breaking news from Aidan Crawley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The University of Oxford spinout's series A round follows up on positive preliminary data from a first-in-human trial earlier this year.
The bank said almost 90 per cent of its registered holders have 20 or fewer shares
It’s okay to gloat about our artistic accomplishments, fruits of a period of social turmoil
The historian discusses an array of subjects, including the damage wrought by Brexit, comparing WB Yeats and Seamus Heaney, and why ‘the whole revisionism thing is over’
Sometimes you just want to push the boat out and eat great food in unique, colourful surroundings